Business
MedMira Receives New Andurja Equity Investment of $ 1.5 million
Jul. 18, 2011 (Canada NewsWire Group) -- Funds to Support a Strategic Refinance Plan includi...
About this update from Medmira Inc.
[{"type":"text","content":"\n\n\n Jul. 18, 2011 (Canada NewsWire Group) -- \n\n#ReleaseContent TABLE\n{\n BORDER-COLLAPSE: collapse\n}\nTR.cnwUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTR.cnwDoubleUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTR.cnwBoldUnderlinedCell TD\n{\n BORDER-BOTTOM: #000000 3px solid\n}\nTD.cnwUnderlinedCell\n{\n BORDER-BOTTOM: #000000 1px solid\n}\nTD.cnwDoubleUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px double\n}\nTD.cnwBoldUnderlinedCell\n{\n BORDER-BOTTOM: #000000 3px solid\n}\n#ReleaseContent TABLE.cnwBorderedTable TD\n{\n BORDER-RIGHT: black 1px solid;\n PADDING-RIGHT: 2px;\n BORDER-TOP: black 1px solid;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n BORDER-LEFT: black 1px solid;\n PADDING-TOP: 2px;\n BORDER-BOTTOM: black 1px solid;\n BORDER-COLLAPSE: collapse\n}\n#ReleaseContent TABLE TD\n{\n PADDING-RIGHT: 2px;\n PADDING-LEFT: 2px;\n PADDING-BOTTOM: 2px;\n PADDING-TOP: 2px\n}\n\n\nFunds to Support a Strategic Refinance Plan including Compromise Debt\n Arrangements \n\n\nHALIFAX, July 18, 2011 /CNW/ - MedMira Inc., ("MedMira") (TSXV: MIR), a\n developer and marketer of rapid diagnostic technology and solutions,\n today announced that it has entered into an agreement with Andurja\n Beteiligungen AG (Andurja), a Swiss company based in Lucerne,\n Switzerland, for a CAD $1.5 million equity investment to begin a\n strategic refinance plan that will use compromise debt arrangements\n intended to reduce the Company's overall debt.\n\n\nAndurja previously invested CAD $2 million in the Company in 2009 and\n CAD $1 million in 2010. Andurja is the controlling and majority\n shareholder of MedMira's strategic partner Vitest AG.\n\n\n"This investment is a first step in restructuring approximately 50% of\n the Company's debt, which represents the largest segment of MedMira's\n annual expenditures. The plan is intended to enhance our credibility\n with key stakeholders including financial partners, customers, and\n suppliers," said Hermes Chan, CEO, MedMira.  "Together with recent\n sales wins, including the U.S. Army contract award, increasing orders\n from China, and the ongoing business development initiatives in global\n markets, this refinancing plan moves the Company in the right\n direction."\n\n\nUnder the terms of the agreement Andurja will acquire 30,000,000 equ...